In pancreatic cancers, SOX2+ PDAC cells could gain cancer stem-like pluripotent potentials through partial EMT phenotypes: upregulation of EMT master regulators (e.g. SNAIL, SLUG, and TWIST), and downregulation of epithelial markers (e.g. E-cadherin and ZO1). This evidence concerns the gene SOX2 and cancer.